Role of small GTP-binding proteins in lovastatin induced cataracts

Published

Conference Paper

Purpose. To investigate suppression of isoprenylation of small GTP-binding proteins as a possible causative biochemical mechanism involved in lovastatin induced cataractogenesis. Methods. The effects of lovastatin on lens epithelial cell proliferation and morphology and on lens transparency have been carried out using cultured epithelial cells from human and rabbit lenses, and organ-cultured rat lenses, respectively. Results. Rat lenses organ cultured with lovastatin, a 3hydroxy-3-methyl glutaryl (HMG)-CoA reductase inhibitor, for one week developed frank subcapsular opacity. Lens epithelial cells (both human and rabbit} demonstrated extensive morphological changes and inhibition of proliferation when treated with lovastatin. Incubation of lenses or lens epithelial cells with both lovastatin and DL-mevalonic acid (a precursor of isoprenoids whose synthesis is inhibited by lovastatin) prevented lovastatin induced changes, whereas incubation with cholesterol and lovastatin did not prevent the changes. An accumulation of GTP-binding proteins in the soluble fractions of lovastatin treated lens epithelial cells was consistent with a blockade in their isoprenylation thereby preventing normal association with membranes. Conclusions. Small GTP-binding proteins play fundamental roles in various cellular processes including growth, differentiation and maintenance of cell morphology. The findings suggest that impairment of the function of small GTP-binding proteins due to blockade in isoprenylation, affects lens cell morphology and proliferation, and induces lens opacity in vitro. None.

Duke Authors

Cited Authors

  • Rao, PV

Published Date

  • December 1, 1997

Published In

Volume / Issue

  • 38 / 4

International Standard Serial Number (ISSN)

  • 0146-0404

Citation Source

  • Scopus